We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
In this issue of Industry Voice we host Zakhar Golant, the chairman of the Union of Pharmaceutical Clusters. We will try to find out about challenges and the purpose of running Pharmaceutical and Biomedical Clusters, learn what pharma and automotive industries have in common, and talk about market access opportunities for international pharma in Eastern Europe based on cases of such companies as Sanofi Aventis, Novo Nordisk, Novartis, Pfizer and Bayer. We will also discuss what future holds for research and development in the next 5-10 years.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
